This is a related question: How are labs planning to address the MU stage 2 requirement to send LOINC codes electronically — specifically, in which OBX, 3.1 or 3.4? And as importantly, what description do the labs and/or clinicians prefer – LOINC Long Name, LOINC Short Name, or the lab’s local terms/abbreviations? I assume that labs are free to use whatever description they want to in conjunction with the LOINC codes.
Thanks again, Daniel. I take it the common order set is intentionally small to enable quicker deployment? Or does Regenstrief consider all the codes that were left out to be in need of review before including them?